MATCHX

Live / Applied — Statement of use — non-final action mailed (as of 09 Sept 2026)

What this means for you

Not registered yet, but its 22 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98513198
Mark type
Stylized text
Filed
22 Apr 2024
Published for opposition
04 Nov 2025
Attorney of record
Deborah J Peckham

Goods and services

  • Class 009 — Scientific and electric apparatus: Downloadable and recorded computer software for performing and reporting antibody analysis; Downloadable and recorded computer software for use in evaluating human leukocyte antigen (HLA) typing test results and for performing antibody screening and antibody crossmatch testing; downloadable and recorded computer software for analyzing and evaluating results of diagnostic tests performed outside a body and in an artificial environment, namely, for testing and reporting on biological samples used in transplantation and disease association; Downloadable and recorded computer software for analyzing and evaluating results of diagnostic tests performed outside a body and in an artificial environment of transplants; Downloadable and recorded computer software for analyzing and evaluating results of diagnostic tests performed outside a body and in an artificial environment of donor-recipient antibody and eplet mapping to evaluate transplant compatibility; Downloadable and recorded computer software for analyzing and evaluating results of diagnostic tests performed outside a body and in an artificial environment of donor genetic material for post-transplant monitoring and diagnosis; Downloadable and recorded computer software for evaluating results of diagnostic tests performed outside a body and in an artificial environment
  • Class 042 — Scientific and technological services: Providing online, non-downloadable computer software for performing and reporting antibody analysis; Providing online, non-downloadable computer software for use in evaluating human leukocyte antigen (HLA) typing test results and for performing antibody screening and antibody crossmatch testing; Providing online, non-downloadable computer software for analyzing and evaluating results of diagnostic tests performed outside a body and in an artificial environment, namely, for testing and reporting on biological samples used in transplantation and disease association; Providing online, non-downloadable computer software for analyzing and evaluating results of diagnostic tests performed outside a body and in an artificial environment of transplants; Providing online, non-downloadable computer software for analyzing and evaluating results of diagnostic tests performed outside a body and in an artificial environment of donor-recipient antibody and eplet mapping to evaluate transplant compatibility; Providing online, non-downloadable computer software for analyzing and evaluating results of diagnostic tests performed outside a body and in an artificial environment of donor genetic material for post-transplant monitoring and diagnosis; Providing online, non-downloadable computer software for evaluating results of diagnostic tests performed outside a body and in an artificial environment

Owner

Prosecution history

  • 09 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 09 Sept 2026 — NON-FINAL ACTION E-MAILED
  • 09 Sept 2026 — SU - NON-FINAL ACTION - WRITTEN
  • 11 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 24 Jun 2026 — USE AMENDMENT FILED
  • 24 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
  • 30 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 04 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 04 Nov 2025 — PUBLISHED FOR OPPOSITION
  • 29 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 01 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 01 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 01 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 01 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 30 Sept 2025 — EXAMINER'S AMENDMENT ENTERED

View this trademark record on Marksy